Regenxbio
RGNX
RGNX
211 hedge funds and large institutions have $1.73B invested in Regenxbio in 2019 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 92 increasing their positions, 51 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
211
Holders Change
+28
Holders Change %
+15.3%
% of All Funds
4.57%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
45
Increased
92
Reduced
51
Closed
17
Calls
$9.38M
Puts
$21.9M
Net Calls
-$12.5M
Net Calls Change
-$11.4M
Top Buyers
| 1 |
PA
1
Perceptive Advisors
New York
|
$65.7M |
| 2 |
CG
2
Carmignac Gestion
Paris,
France
|
$36.6M |
| 3 |
3
T. Rowe Price Associates
Baltimore,
Maryland
|
$41.3M |
| 4 |
4
SG Americas Securities
New York
|
$10.3M |
| 5 |
5
Bank of New York Mellon
New York
|
$38.5M |
Top Sellers
| 1 |
RI
1
RTW Investments
New York
|
$25.9M |
| 2 |
HCM
2
Highline Capital Management
New York
|
$10.4M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$95.9M |
| 4 |
4
Morgan Stanley
New York
|
$4.54M |
| 5 |
5
Wellington Management Group
Boston,
Massachusetts
|
$29.2M |
